BTC Health Limited (BTC.AX)
| Previous close | 0.0830 |
| Open | 0.0830 |
| Bid | 0.0830 x 7867300 |
| Ask | 0.0850 x 1875100 |
| Day's range | 0.0830 - 0.0830 |
| 52-week range | 0.0670 - 0.1950 |
| Volume | 11,100 |
| Avg. volume | 179,119 |
| Market cap | 23.393M |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0020 |
| Earnings date | 17 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 19 Oct 2012 |
| 1y target est | N/A |
- ABN Newswire
BTC Health Limited (BTC.AX) Shareholder Update - September 2021
I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.
- ABN Newswire
BTC Health Limited (BTC.AX) Annual Report - 30 June 2021
The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.
- ABN Newswire
BTC Health Limited (BTC.AX) Acquires Exclusive Distribution Rights for Bronchitol(R) and Aridol(R) from Pharmaxis
BTC Health Limited (ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (ASX:PXS) in Australia, New Zealand, Singapore, Malaysia, Hong Kong and South Korea (Bronchitol(R) only).
